ACO Name and Location

Orlando Health Collaborative Care
1414 Kuhl Ave. MP2
Orlando, Florida 32806 

ACO Primary Contact

Primary Contact Name	Robyn Bartek
Primary Contact Phone Number	321.843.8366
Primary Contact Email Address	[email protected]

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture (Enter Y or N)
West Orange Physicians Group, LLC	N
Orlando Health, Inc.	N
Orlando Physicians Network, Inc	N
Orlando Health Physician Group, Inc.	N
South Lake Hospital, Inc.	N
Physician Associates, LLC	N

ACO governing body:

Member			Member's Voting Power	Membership Type	ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name	First Name	Title/Position
Senne	Jerry	Executive Director	1	ACO Participant Representative	Orlando Health
Spong	Bernadette	Chief Financial Officer, Orlando Health	1	ACO Participant Representative	Orlando Health
Burket	Brandon	AVP, Value Based Care & Population Health	1	ACO Participant Representative	Orlando Health
Walker	Erik	MD	1	ACO Participant Representative	Orlando Health Physician Associates
Kaplan	Benjamin	MD	1	ACO Participant Representative	Orlando Physicians Network
Jackson	Amy	MD	1	ACO Participant Representative	West Orange Physician Group
Soto	Martin	MD	1	ACO Participant Representative	Orlando Health Physician Associates
Desai	Sunil	MD	1	ACO Participant Representative	Orlando Health Physician Group, Inc.
MacDiarmid	Malcolm		1	Medicare Beneficiary Representative

Key ACO clinical and administrative leadership:

Jerry Senne	ACO Executive
Martin Soto	Medical Director
Dave Huddleson	Compliance Officer
Benjamin Kaplan	Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Quality Improvement and Care Coordination	Benjamin Kaplan, MD, Chair
Finance and Operations	Erik Walker, MD, Chair
Compliance	David Huddleson, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

• ACO professionals in a group practice arrangement
• Hospital employing ACO professionals
• Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

• Second Agreement Period

• Performance Year 2018, $3,099,021
• Performance Year 2017, $0
• Performance Year 2016, $0

• First Agreement Period

• Performance Year 2015, $2,696,226
• Performance Year 2014, $2,421,969
• Performance Year 2013, $1,469,180 

Shared Savings Distribution

• Second Agreement Period

• Performance Year 2018

• Proportion invested in infrastructure: 20%
• Proportion invested in redesigned care processes/resources: 40%
• Proportion of distribution to ACO participants: 40%

• Performance Year 2017

• Proportion invested in infrastructure: N/A
• Proportion invested in redesigned care processes/resources: N/A
• Proportion of distribution to ACO participants: N/A

• Performance Year 2016

• Proportion invested in infrastructure: N/A
• Proportion invested in redesigned care processes/resources: N/A
• Proportion of distribution to ACO participants: N/A

• First Agreement Period

• Performance Year 2015

• Proportion invested in infrastructure: 20%
• Proportion invested in redesigned care processes/resources: 40%
• Proportion of distribution to ACO participants: 40%

• Performance Year 2014

• Proportion invested in infrastructure: 20%
• Proportion invested in redesigned care processes/resources: 40%
• Proportion of distribution to ACO participants: 40%

• Performance Year 2013

• Proportion invested in infrastructure: 20%
• Proportion invested in redesigned care processes/resources: 40%
• Proportion of distribution to ACO participants: 40% 

Quality Performance Results

2018 Quality Performance Results:

ACO#	Measure Name	Rate	ACO Mean
ACO-1	CAHPS: Getting Timely Care, Appointments, and Information	84.69	86.14
ACO-2	CAHPS: How Well Your Providers Communicate	92.56	93.93
ACO-3	CAHPS: Patients’ Rating of Provider	90.87	92.45
ACO-4	CAHPS: Access to Specialists	82.07	81.50
ACO-5	CAHPS: Health Promotion and Education	61.57	59.26
ACO-6	CAHPS: Shared Decision Making	59.15	61.94
ACO-7	CAHPS: Health Status/Functional Status	73.84	73.35
ACO-34	CAHPS: Stewardship of Patient Resources	24.16	26.26
ACO-8	Risk Standardized, All Condition Readmission	14.71	14.98
ACO-35	Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)	18.01	18.59
ACO-36	All-Cause Unplanned Admissions for Patients with Diabetes	32.64	37.01
ACO-37	All-Cause Unplanned Admissions for Patients with Heart Failure	64.88	76.75
ACO-38	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	53.57	59.00
ACO-43	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	1.60	1.98
ACO-11	Use of Certified EHR Technology	100.00	98.20
ACO-12	Medication Reconciliation	87.76	85.91
ACO-13	Falls: Screening for Future Fall Risk	98.51	79.73
ACO-44	Imaging Studies for Low Back Pain	64.71	64.36
ACO-14	Preventive Care and Screening: Influenza Immunization	86.35	72.71
ACO-15	Pneumonia Vaccination Status for Older Adults	88.80	75.97
ACO-16	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up	92.07	76.83
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	86.67	72.81
ACO-18	Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan	75.50	66.74
ACO-19	Colorectal Cancer Screening	81.79	68.27
ACO-20	Breast Cancer Screening	77.30	71.96
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	85.91	81.47
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	10.41	15.51
ACO-41	Diabetes: Eye Exam	61.77	52.42
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	73.68	73.10
ACO-30	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic	84.15	88.92

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. 

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

• Yes, our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612.